Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
about
The Protective Effects of Nigella sativa and Its Constituents on Induced NeurotoxicityCloning and identification of a novel human gene PDLIM5, a homolog of AD-associated neuronal thread protein (AD7c-NTP)Biomarkers for early detection of Alzheimer pathology.Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.Biomarkers in Alzheimer's disease: past, present and future.Deliberative assessment of surrogate consent in dementia research.Toward a comprehensive neurobiology of IGF-I.Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjectsMultifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugsEffectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial.Biomarkers for apoptosis in Alzheimer's disease.Cholesterol and apolipoprotein E in Alzheimer's disease.Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer's Rodent Models.Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formationIs B vitamins deficiency associated with prevalence of Alzheimer's disease in Cuban elderly?Current experimental therapy for Alzheimer's diseasePresent and prospective clinical therapeutic regimens for Alzheimer's disease.Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.IGF-IR in neuroprotection and brain tumors.Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.Drug delivery strategies for Alzheimer's disease treatment.Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.Psychotic symptoms in the elderly.Genetics and diagnostic refinement.Biodegradable donepezil lipospheres for depot injection: optimization and in-vivo evaluation.What does the Medicare prescription drug legislation mean for the American cardiologist?Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.Donepezil treatment of topiramate-related cognitive dysfunction.Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors.Lay perceptions regarding the competence of persons with Alzheimer's disease.Transport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosa.Neurodegenerative processes in Alzheimer’s disease: an overview of pathogenesis with strategic biomarker potentialImportance of GPCR-Mediated Microglial Activation in Alzheimer's Disease
P2860
Q26775778-A55DA2E1-74C3-44B5-9DDD-2DD3570C2B7AQ28280377-E95BE6D9-7CC7-4491-951A-DFA5D201E577Q31140680-248843E8-586C-4224-96D5-DFEA5EF1284BQ33617203-9481801A-C0AB-4BA9-B867-9AD6D4E0EE9CQ33791646-63DDE57F-B3ED-459B-A1BA-574E1699204BQ33927499-E3245330-2836-485B-8D5B-AF95400EA5FDQ34100780-730D6BD0-AEE4-4822-8D51-6C0DB3F2F956Q34271896-09781819-C93A-4769-AC64-A6183853FE45Q34911093-CB8BC60F-7A30-407B-9FF8-D5DBB4FAA1C7Q35276747-F2DCF414-3247-4905-9231-DEF47B314804Q36014518-273173F3-DE8C-4FA1-BF11-25AAB15FDAA8Q36103897-FA383B42-9E60-4763-8518-4531A4EC5D58Q36107258-9FABFA27-AE9D-4FF0-BD98-D77414A9E8F3Q36158803-824005AE-2786-472B-ABF7-812E8C165C27Q36298522-61666CB8-5D9B-4916-B6BF-2D2124B03919Q36542979-78C68227-9224-484D-8AAE-AD23D44B2E6EQ36731881-83C5A005-507F-4458-82F6-5180E8C72F9BQ36876447-4D04DDAD-4148-471B-9D26-2839329700C0Q37405505-3D75CB83-5AA6-4227-BFCF-1681DB08A572Q37409955-F2AB17B7-F609-4A78-B520-7B31A1914C4FQ37448875-ADE0D3F8-E914-41A4-88C7-22FFAB1288CDQ37524486-AA9CEAB0-A0DE-4815-B3A8-37AC295C56CEQ37764347-E82FC323-E1D6-461A-8913-44D000CF635DQ37851509-2762F6B1-0537-4E83-8466-FF6288B4BCB3Q39626472-5137E79B-516C-44EC-8DFD-BBBF77C71D1AQ42133419-AE92A357-4F82-47A0-8FAF-440A4544F34EQ42605907-438F0BCA-1DE8-46B1-BEE9-BEF0745F8EFFQ44014924-5ABBD8FC-9B37-4898-8B99-24611CC53C3EQ44333941-6B14D5A9-F52F-4A36-8919-CCCE8CC3B2A1Q46315298-8A943968-F6E2-4301-9218-785228FAFB08Q46955607-465744A9-DD5E-4093-A001-11DE10A416F7Q50744649-54B2A19D-1378-4DE9-B32F-8B829A85FCC6Q50933055-CE814E45-8BE4-46C2-BF1D-65A0DE62560DQ53383867-FA8F0002-D0CF-4016-9394-62C50C112FD2Q57341313-A9E7FC4B-C687-4B40-93EB-FA707ECCBE2DQ58729326-2B59D507-39F3-457E-9998-B69EEEEFD7D5
P2860
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@ast
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@en
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@nl
type
label
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@ast
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@en
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@nl
prefLabel
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@ast
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@en
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@nl
P1476
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
@en
P2093
Christopher M Clark
Jason H T Karlawish
P304
P356
10.7326/0003-4819-138-5-200303040-00010
P407
P577
2003-03-01T00:00:00Z